- Home
- RGNX vs ABSI Comparison
RGNX vs ABSI Comparison
Compare RGNX & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- ABSI
- Stock Information
- Founded
- RGNX 2008
- ABSI 2011
- Country
- RGNX United States
- ABSI United States
- Employees
- RGNX N/A
- ABSI N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- RGNX Health Care
- ABSI Health Care
- Exchange
- RGNX Nasdaq
- ABSI Nasdaq
- Market Cap
- RGNX 356.7M
- ABSI 318.2M
- IPO Year
- RGNX 2015
- ABSI 2021
- Fundamental
- Price
- RGNX $7.27
- ABSI $4.96
- Analyst Decision
- RGNX Buy
- ABSI Strong Buy
- Analyst Count
- RGNX 12
- ABSI 7
- Target Price
- RGNX $33.36
- ABSI $8.57
- AVG Volume (30 Days)
- RGNX 698.7K
- ABSI 5.4M
- Earning Date
- RGNX 02-28-2025
- ABSI 03-20-2025
- Dividend Yield
- RGNX N/A
- ABSI N/A
- EPS Growth
- RGNX N/A
- ABSI N/A
- EPS
- RGNX N/A
- ABSI N/A
- Revenue
- RGNX $84,327,000.00
- ABSI $4,207,000.00
- Revenue This Year
- RGNX $2.23
- ABSI $7.92
- Revenue Next Year
- RGNX $250.77
- ABSI $162.34
- P/E Ratio
- RGNX N/A
- ABSI N/A
- Revenue Growth
- RGNX N/A
- ABSI N/A
- 52 Week Low
- RGNX $6.56
- ABSI $2.45
- 52 Week High
- RGNX $28.80
- ABSI $6.72
- Technical
- Relative Strength Index (RSI)
- RGNX 41.90
- ABSI 58.10
- Support Level
- RGNX $6.92
- ABSI $4.17
- Resistance Level
- RGNX $7.79
- ABSI $6.33
- Average True Range (ATR)
- RGNX 0.44
- ABSI 0.54
- MACD
- RGNX -0.04
- ABSI 0.03
- Stochastic Oscillator
- RGNX 19.40
- ABSI 53.24
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.